| Time | Session |
|---|
|
5:45 p.m.
6:45 p.m.
|
MEASUREMENT OF CEREBRAL BLOOD FLOW USING TRANSCRANIAL DOPPLER ULTRASOUND: COMPARISON OF TWO POPULATIONS OF PATIENTS IN CHRONIC HEMODIALYSIS
WCN24-AB-1464, Poster Board= MON-038
Omar Fueyo
Poster Presenter
|
EFFICACY OF TENAPANOR AS A PHOSPHATE-LOWERING THERAPY IN PATIENTS WITH END-STAGE KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
WCN24-AB-1073, Poster Board= MON-039
Maria Gabriela Guimarães
Poster Presenter
|
FACTORS INFLUENCING THE ONSET OF CARDIOVASCULAR COMPLICATIONS ACCORDING TO CHRONIC KIDNEY DISEASE STAGES: A MULTI-CENTER PROSPECTIVE COHORT
WCN24-AB-776, Poster Board= MON-040
Intissar Haddiya
Poster Presenter
|
A RANDOMIZED CONTROLLED TRIAL OF ALLOPURINOL FOR CVD IN CKD: STUDY POPULATION CHARACTERISTICS
WCN24-AB-2260, Poster Board= MON-041
Vivek Kumar
Poster Presenter
|
ROLE OF NICOTINAMIDE ON PHOSPHORUS METABOLISM IN DIALYSIS PATIENTS: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS
WCN24-AB-159, Poster Board= MON-042
Larissa Lucena
Poster Presenter
|
Unveiling the Burden of Helicobacter Pylori Infection among Chronic Kidney Disease Patients in Bangladesh
WCN24-AB-1585, Poster Board= MON-043
Farnaz Nobi
Poster Presenter
|
ENFERMEDAD RENAL QUISTICA ADQUIRIDA EN PACIENTES DE LA UNIDAD DE HEMODIALISIS DEL HOSPITAL SALVADOR B. GAUTIER, OCTUBRE 2022- MARZO 2023
WCN24-AB-1094, Poster Board= MON-044
Lisxandri Pérez Díaz
Poster Presenter
|
ALDOSTERONE SYNTHASE INHIBITION WITH OR WITHOUT BACKGROUND SODIUM GLUCOSE COTRANSPORTER 2 INHIBITION IN CKD: A PHASE II CLINICAL TRIAL
WCN24-AB-1550, Poster Board= MON-045
Katherine Tuttle
Poster Presenter
|
SODIUM THIOSSULFATE TREATMENT FOR CALCIPHYLAXIS: IS THERE AN OPTIMAL DURATION OF THERAPY?
WCN24-AB-1997, Poster Board= MON-046
Julia Vaz
Poster Presenter
|
CLINICAL CHARACTERISTICS AND PREDICTIVE MODEL FOR SEVERE CORONARY ARTERY CALCIFICATION IN END-STAGE KIDNEY DISEASE PATIENTS
WCN24-AB-747, Poster Board= MON-047
Ningning Wang
Poster Presenter
|